TLR4 and hepatocellular carcinoma: EVs’ modulation of TLR4 signaling emerges as a promising avenue for immune modulation in HCC, with studies showing the EV-mediated effects on TLR4 pathways that impact inflammation, macrophage polarization, and HCC progression.